| Patents for C07D 473 - Heterocyclic compounds containing purine ring systems (11,932) |
|---|
| 03/15/2011 | US7906518 Therapeutic compounds |
| 03/15/2011 | CA2528385C A1 adenosine receptor antogonists |
| 03/15/2011 | CA2397366C Methanocarba cycloalkyl nucleoside analogues |
| 03/15/2011 | CA2379575C Pharmaceutically active sulfonamide derivatives |
| 03/10/2011 | WO2011028507A2 Compositions, methods, and kits for determining an alkyl transferase |
| 03/10/2011 | US20110059995 Substituted xanthine derivatives |
| 03/10/2011 | US20110059974 Novel retinamide retinoic acid metabolism blocking agents |
| 03/10/2011 | US20110059941 2-phenyl substituted imidazol [4,5b] pyridine/pyrazine and purine derivatives as glucokinase modulators |
| 03/10/2011 | US20110059921 Oligomer-Nitrogenous Base Conjugates |
| 03/10/2011 | CA2771331A1 Substituted xanthine derivatives |
| 03/10/2011 | CA2771123A1 Substituted xanthine derivatives |
| 03/09/2011 | EP2292620A2 Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prohylaxis and treatment of disorders related thereto |
| 03/09/2011 | EP2292619A1 Purine derivatives for use as adenonsin A-2A receptor agonists |
| 03/09/2011 | EP2007766B1 Narcotine purification process |
| 03/09/2011 | EP1874770B1 Phenylacetamides suitable as protein kinase inhibitors |
| 03/08/2011 | US7902360 e.g. 3-[2-(4-aminophenyl)ethyl]-8-benzyl-7-(2-ethylamino)ethyl-1-propylxanthine; A1-adenosine receptor antagonist; antiallergen, antiinflammatory agent; AIDS and immune deficiency disorders, asthma; good water solubility |
| 03/08/2011 | US7902187 6-substituted 2-(benzimidazolyl)purine and purinone derivatives for immunosuppression |
| 03/08/2011 | CA2488202C 1-aryl-4-substituted piperazine derivatives for use as ccr1 antagonists for the treatment of inflammation and immune disorders |
| 03/03/2011 | WO2011022757A1 Purine-targeted diagnosis and therapy of wounds |
| 03/03/2011 | US20110054168 Method for preparing adenine compound |
| 03/03/2011 | US20110053961 Substituted xanthine derivatives |
| 03/03/2011 | US20110053920 Substituted bicyclic pyrimidines |
| 03/03/2011 | US20110053858 Heterocyclic peptide ketoamides |
| 03/02/2011 | EP2289893A1 Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith |
| 03/02/2011 | EP2288351A2 Novel pyrrolidone derivatives for use as metap-2 inhibitors |
| 03/02/2011 | EP1668011B1 Hiv replication inhibiting purine derivatives |
| 03/01/2011 | US7897628 {2-[3-(4-Methyl-2-[2-methypropoxy]phenyl)-ureido]-thiazol-4-yl}-acetic acid ethyl ester; glucokinase inhibitor; antidiabetic, hypoglycemic agent; activators of glucokinase |
| 02/24/2011 | US20110046369 Method for preparing adenine compound |
| 02/24/2011 | US20110046368 Ligands of 5-ht6 receptors, a pharmaceutical composition, method for the production and use thereof |
| 02/24/2011 | US20110046166 Purine derivatives as a3 adenosine receptor-selective agonists |
| 02/24/2011 | US20110046165 Certain chemical entitles, compositions and methods |
| 02/24/2011 | US20110046132 Benzoimidazoles as prolyl hydroxylase inhibitors |
| 02/24/2011 | US20110046131 Purines as pkc-theta inhibitors |
| 02/23/2011 | EP2287166A2 Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
| 02/23/2011 | EP2287165A2 Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
| 02/23/2011 | EP2287164A1 Process for the manufacture of chiral 8-(3-aminopiperidin-1-yl)-xanthines |
| 02/17/2011 | WO2011019752A2 A1 adenosine receptor agonist polymorphs |
| 02/17/2011 | WO2011018771A2 Process for the preparation of valganciclovir hydrochloride |
| 02/17/2011 | US20110039798 Substituted nucleoside derivatives with antiviral and antimicrobial properties |
| 02/16/2011 | CN101973959A 4-methyl-1,2,3-thiadiazole-5-formyl urea compounds and preparation method and application thereof |
| 02/16/2011 | CN101456860B Process for preparing 4-[9-(6-aminopurine)]-2(S)-hydroxybutyrate methyl ester |
| 02/15/2011 | CA2628883C Novel 3'-modified oligonucleotide derivatives |
| 02/10/2011 | WO2011016611A2 Adefovir dipivoxil having a novel crystal form, a production method for the same, and a composition for preventing or treating chronic hepatitis b containing the same as an active ingredient |
| 02/10/2011 | WO2011016044A1 Novel polymorphs of adefovir dipivoxil |
| 02/09/2011 | EP1943251B1 A1 adenosine receptor agonists |
| 02/09/2011 | CN101967146A Ep4 receptor inhibitors to treat rheumatoid arthritis |
| 02/08/2011 | US7884202 Nucleobases are perfluoroalkylated in a one step process with a perfluoroalkyl halide in the presence of a sulfoxide, a peroxide and an iron compound; useful as medicinal drugs, intermediates for medicinal drugs and agricultural chemicals |
| 02/08/2011 | US7884110 4-Chloro-N-[5-methyl-2-(7H-pyrrolo[2,3-d]pyrimidine-4-carbonyl)-pyridin-3-yl]-3-trifluoromethyl-benzenesulfonamide sodium salt; for chemokine-mediated conditions or diseases including certain inflammatory and immunoregulatory disorders; restenosis, multiple sclerosis, arthritis |
| 02/08/2011 | US7884109 immunosuppressants such as 2-(6-Fluoro-1H-benzo[d]imidazol-1-yl)-9-((1R,4R)-4-hydroxy-1,2,3,4-tetrahydronaphthalen-1-yl)-7H-purin-8(9H)-one, used for the prevention and treatment of autoimmune diseases, inflammatory disease, mast cell mediated disease and transplant rejection |
| 02/08/2011 | US7884100 selective antagonists of A2B adenosine receptors for treatment of asthma, diabetic retinopathy |
| 02/03/2011 | WO2011012269A2 Method and substances for preparation of n-substituted pyridinium compounds |
| 02/03/2011 | WO2010110622A9 Novel crystal forms of adefovir dipivoxil and processes for preparing the same |
| 02/03/2011 | US20110028715 Novel adenine compound |
| 02/03/2011 | US20110028497 Novel derivatives of purinic and pyrimidinic antiviral agents and use thereof as potent anticancer agents |
| 02/03/2011 | US20110028337 Nucleobase characterisation |
| 02/03/2011 | CA2769154A1 Method and substances for preparation of n-substituted pyridinium compounds |
| 02/02/2011 | EP2279188A1 Purine pi3k inhibitor compounds and methods of use |
| 02/02/2011 | CN101962390A Fluorescently tagged ligands |
| 02/01/2011 | US7879864 Substituted 8-aminoalkoxy-xanthine compounds and compositions useful in the treatment of hyperlipidemia and diabetes |
| 02/01/2011 | US7879863 Aniline derivatives |
| 02/01/2011 | US7879371 using heat resistant elements to transfer heterologous nucleotide sequences into plants; efficient and cost-effective method of introducing Agrobacterium-mediated genetic transformation into plant systems using said caffeine fraction of tea leaves |
| 01/27/2011 | WO2010090491A3 Novel salts of adefovir dipivoxil and preparation method thereof |
| 01/27/2011 | US20110021541 Inhibitors of human phosphatidyl-inositol 3-kinase delta |
| 01/27/2011 | US20110020388 Targeted synthetic nanocarriers with ph sensitive release of immunomodulatory agents |
| 01/26/2011 | CN101955494A Metal complexes of N-heterocyclic carbenes as radiopharmaceuticals and antibiotics |
| 01/26/2011 | CN101955481A Method for preparing valganciclovir hydrochloride |
| 01/25/2011 | US7875620 Methods of treating microbial infections |
| 01/25/2011 | US7875608 Substituted 8-[6-amino-3pyridyl]xanthines |
| 01/25/2011 | US7875603 phenyl-, pyridyl-, pyrimidyl- and purine- derivatives; anticarcinogenic agent; solid tumor: breast, colorectal, lung, prostate, and ovarian |
| 01/25/2011 | US7875467 Chemiluminescence; quantitative analysis of macromolecules; complexing sample to acridinium compound, labels for improving sensitivity of immunoassays, 2',6'-dimethyl-4'-N-succinimidyloxycaproyl-amidocarbonylphenyl-N10-2,7-tris[O-methoxyhexa(ethylene) glycol-sulfonamidylpropyl]-acridinium-9-carboxylate |
| 01/20/2011 | WO2011008487A1 Pyrimidinones as pi3k inhibitors |
| 01/20/2011 | WO2011006567A1 Aminopyridine derivatives for treating tumors and inflammatory diseases |
| 01/20/2011 | WO2010003475A8 Novel pyrrolidone derivatives for use as metap-2 inhibitors |
| 01/20/2011 | US20110015212 Pyrimidinones as pi3k inhibitors |
| 01/20/2011 | US20110014196 Drug Transfer into Living Cells |
| 01/20/2011 | CA2768169A1 Aminopyridine derivatives for the treatment of tumors and inflammatory diseases |
| 01/20/2011 | CA2766100A1 Pyrimidinones as pi3k inhibitors |
| 01/19/2011 | EP2275395A2 Copper-catalyzed formation of carbon-carbon bonds |
| 01/19/2011 | EP2274282A1 Compounds for use in stabilizing p53 mutants |
| 01/19/2011 | EP1534255B1 Processes for preparing 1,3-dioxolane nucleosides |
| 01/19/2011 | EP1067123B1 Nitrogenous heterocyclic compounds |
| 01/19/2011 | CN101343270B Method for extracting tea polyphenol and theine from tea simultaneously |
| 01/18/2011 | US7871991 Phosphonate analogs of HIV inhibitor compounds |
| 01/13/2011 | WO2011005871A1 Substituted 8-[6-carbonylamine-3-pyridyl]xanthines as adenosine a2b antagonists |
| 01/13/2011 | US20110009623 Selective growth of stable polymorphs |
| 01/13/2011 | US20110009607 Method for preparing dna fragment having sticky end |
| 01/12/2011 | EP2272848A1 Xanthine derivatives as selective HM74A agonists |
| 01/12/2011 | EP2272813A2 Copper-catalyzed formation of carbon-oxygen bonds |
| 01/12/2011 | EP2272517A1 Ortho-condensed pyridine and pyrimidine derivatives ( e.g. purines ) as protein kinases inhibitors |
| 01/12/2011 | EP2271631A2 Inhibitors of protein kinases |
| 01/12/2011 | EP1334103B1 Methods for treatment of disease-induced peripheral neuropathy and related conditions |
| 01/12/2011 | CN101941973A Benzoglioxaline-4-amide type derivative, preparation method, medical composition and application thereof |
| 01/12/2011 | CN101050216B Method for synthesizing medication Entecavir of anti hepatitis B |
| 01/11/2011 | US7868204 Inhibitors of histone deacetylase |
| 01/11/2011 | US7868011 Hemorrhagic virus infection, autoimmune diseases, autograft rejection, neoplasm, hyperhomocysteineuria, cardiovascular disease, stroke, Alzheimer's disease, or diabetes; can be used in combination with an anti-hemorrhagic viral infection agent, an immunosuppressant; kits |
| 01/11/2011 | US7867629 2,4-Diphenyl-6-(10-phenyl-anthracen-9-yl-pyrimidine; achieves elevation of luminance; excellent efficiency of light emission; long lifetime by an improvement of an electrode adhesion; durability; stability; OLED/organic light emitters |
| 01/11/2011 | US7867526 Composition for weight reduction comprising capsaicin, green tea extract, L-tyrosine and caffeine |
| 01/06/2011 | US20110003834 Production method and production apparatus for a high theobromine-containing composition |
| 01/06/2011 | US20110003806 Heteroaryls and uses thereof |
| 01/05/2011 | EP2268641A2 Heterocyclic compounds as adenosine receptor antagonist |